单药治疗-话题@MedSci

#单药治疗#

130篇内容 | 3015人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687779, encodeId=f447168e779dc, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？, objectType=article, longId=295417, objectId=c68f29541e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68f29541e66, replyNumber=0, likeNumber=85, createdTime=2022-04-17, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68f29541e66, moduleTitle=Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68f29541e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687789, encodeId=5180168e7895f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：派姆单抗单药治疗初治晚期肝细胞癌, objectType=article, longId=726090, objectId=0c95e260900a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c95e260900a, replyNumber=0, likeNumber=81, createdTime=2023-03-23, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c95e260900a, moduleTitle=Clin Cancer Res：派姆单抗单药治疗初治晚期肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c95e260900a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687782, encodeId=1eb5168e78201, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=J Invest Dermatol：阿达木单抗联合甲氨蝶呤与阿达木单抗单药治疗银屑病疗效对比, objectType=article, longId=301378, objectId=829a3013e89e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=829a3013e89e, replyNumber=0, likeNumber=90, createdTime=2022-11-28, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=829a3013e89e, moduleTitle=J Invest Dermatol：阿达木单抗联合甲氨蝶呤与阿达木单抗单药治疗银屑病疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=829a3013e89e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687786, encodeId=79c4168e78626, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低, objectType=article, longId=723921, objectId=e27de239212b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27de239212b, replyNumber=0, likeNumber=71, createdTime=2022-09-17, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27de239212b, moduleTitle=GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27de239212b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687762, encodeId=2103168e7622c, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关, objectType=article, longId=215687, objectId=dd9b21568e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd9b21568e2a, replyNumber=0, likeNumber=74, createdTime=2021-12-24, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd9b21568e2a, moduleTitle=Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd9b21568e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687775, encodeId=a1c9168e77514, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果, objectType=article, longId=221530, objectId=eb62221530ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb62221530ea, replyNumber=0, likeNumber=88, createdTime=2022-07-07, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb62221530ea, moduleTitle=Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb62221530ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687788, encodeId=830b168e7884d, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=JAMA Cardiol：急性冠脉综合征患者双重抗血小板治疗1-2个月后改为氯吡格雷单药治疗的效果, objectType=article, longId=724765, objectId=f4c4e24765ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4c4e24765ec, replyNumber=0, likeNumber=90, createdTime=2023-02-18, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4c4e24765ec, moduleTitle=JAMA Cardiol：急性冠脉综合征患者双重抗血小板治疗1-2个月后改为氯吡格雷单药治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4c4e24765ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687764, encodeId=c88e168e76493, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果, objectType=article, longId=216691, objectId=f8e221669147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e221669147, replyNumber=0, likeNumber=90, createdTime=2021-12-04, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e221669147, moduleTitle=Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8e221669147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687780, encodeId=efe4168e78006, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=THER ADV GASTROENTER：甲氨蝶呤单药治疗成人克罗恩病患者的短期耐受性和有效性分析, objectType=article, longId=299696, objectId=dee929969679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dee929969679, replyNumber=0, likeNumber=94, createdTime=2022-04-27, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dee929969679, moduleTitle=THER ADV GASTROENTER：甲氨蝶呤单药治疗成人克罗恩病患者的短期耐受性和有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dee929969679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687758, encodeId=cf9b168e75868, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Eur J Cancer：奥拉帕利单药治疗gBRCAm-HER2阴性转移性乳腺癌的实际临床疗效, objectType=article, longId=212462, objectId=1f99212462e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f99212462e3, replyNumber=0, likeNumber=80, createdTime=2021-07-26, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f99212462e3, moduleTitle=Eur J Cancer：奥拉帕利单药治疗gBRCAm-HER2阴性转移性乳腺癌的实际临床疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f99212462e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687757, encodeId=f8d1168e7570f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet Oncol：派姆单抗单药治疗BCG-无应答性高危型非肌肉浸润性膀胱癌的疗效, objectType=article, longId=211961, objectId=5b9821196102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9821196102, replyNumber=0, likeNumber=87, createdTime=2021-11-12, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9821196102, moduleTitle=Lancet Oncol：派姆单抗单药治疗BCG-无应答性高危型非肌肉浸润性膀胱癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9821196102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687761, encodeId=9669168e761ef, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效, objectType=article, longId=215476, objectId=dc262154e628, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc262154e628, replyNumber=0, likeNumber=83, createdTime=2021-11-25, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc262154e628, moduleTitle=Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc262154e628)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687781, encodeId=d896168e7811b, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Blood：西罗莫司+泼尼松龙 vs 西罗莫司单药治疗卡波西样血管内皮瘤, objectType=article, longId=299752, objectId=31b6299e52cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b6299e52cd, replyNumber=0, likeNumber=75, createdTime=2022-09-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b6299e52cd, moduleTitle=Blood：西罗莫司+泼尼松龙 vs 西罗莫司单药治疗卡波西样血管内皮瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31b6299e52cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687778, encodeId=4ee5168e77893, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤, objectType=article, longId=294798, objectId=9a57294e98ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a57294e98ea, replyNumber=0, likeNumber=78, createdTime=2022-11-11, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a57294e98ea, moduleTitle=Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a57294e98ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687763, encodeId=f9b4168e7636b, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, objectType=article, longId=216217, objectId=7a6e21621ef1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6e21621ef1, replyNumber=0, likeNumber=94, createdTime=2022-01-31, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6e21621ef1, moduleTitle=Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6e21621ef1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687760, encodeId=e8a9168e7604f, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Lancet：新型双GIP和GLP-1受体激动剂单药治疗可以显著改善糖尿病血糖和体重水平, objectType=article, longId=213906, objectId=58312139068b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58312139068b, replyNumber=0, likeNumber=104, createdTime=2022-02-07, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58312139068b, moduleTitle=Lancet：新型双GIP和GLP-1受体激动剂单药治疗可以显著改善糖尿病血糖和体重水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58312139068b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687776, encodeId=2793168e77646, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Clin Cancer Res：PARP抑制剂Pamiparib单药治疗铂敏感/耐药性卵巢癌的疗效, objectType=article, longId=221549, objectId=315622154982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=315622154982, replyNumber=0, likeNumber=81, createdTime=2022-08-24, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=315622154982, moduleTitle=Clin Cancer Res：PARP抑制剂Pamiparib单药治疗铂敏感/耐药性卵巢癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=315622154982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687771, encodeId=3329168e77168, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Front Oncol：卡瑞利珠单抗联合索拉非尼vs 索拉非尼单药治疗晚期肝细胞癌（HCC）的有效性和安全性, objectType=article, longId=219191, objectId=02ce219191a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02ce219191a0, replyNumber=0, likeNumber=72, createdTime=2021-12-18, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02ce219191a0, moduleTitle=Front Oncol：卡瑞利珠单抗联合索拉非尼vs 索拉非尼单药治疗晚期肝细胞癌（HCC）的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02ce219191a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687774, encodeId=9490168e77461, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, objectType=article, longId=221017, objectId=e99622101e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99622101e22, replyNumber=0, likeNumber=75, createdTime=2022-08-22, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99622101e22, moduleTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99622101e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687772, encodeId=547a168e77284, content=<a href='/topic/show?id=be223633375' target=_blank style='color:#2F92EE;'>#单药治疗#</a>, objectTitle=Diabetes Obes Metab：二甲双胍单药治疗2型糖尿病和既往3期慢性肾病的疗效, objectType=article, longId=219912, objectId=cf9321991272, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf9321991272, replyNumber=0, likeNumber=91, createdTime=2021-11-12, rootId=0, userName=12498717m75(暂无昵称), userId=2bef28414326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf9321991272, moduleTitle=Diabetes Obes Metab：二甲双胍单药治疗2型糖尿病和既往3期慢性肾病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf9321991272)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

单药治疗

2020-05-29

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Eur Urol Focus：Nivolumab单药治疗晚期肾细胞癌的疗效如何？

2022-04-17

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：派姆单抗单药治疗初治晚期肝细胞癌

2023-03-23

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

J Invest Dermatol：阿达木单抗联合甲氨蝶呤与阿达木单抗单药治疗银屑病疗效对比

2022-11-28

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

GUT: 与维多珠单抗单药治疗相比，维多珠单抗和硫嘌呤类药物联合治疗克罗恩病失效的风险更低

2022-09-17

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：早早使用大剂量激素管理irAE与抗PD-1单药治疗晚期黑色素瘤的预后不良相关

2021-12-24

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：HER2双特异性抗体KN026单药治疗HER2+转移性乳腺癌的临床试验结果

2022-07-07

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

JAMA Cardiol：急性冠脉综合征患者双重抗血小板治疗1-2个月后改为氯吡格雷单药治疗的效果

2023-02-18

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：维奈托克单药治疗复发/难治性非霍奇金淋巴瘤的长期随访结果

2021-12-04

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

THER ADV GASTROENTER：甲氨蝶呤单药治疗成人克罗恩病患者的短期耐受性和有效性分析

2022-04-27

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Eur J Cancer：奥拉帕利单药治疗gBRCAm-HER2阴性转移性乳腺癌的实际临床疗效

2021-07-26

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet Oncol：派姆单抗单药治疗BCG-无应答性高危型非肌肉浸润性膀胱癌的疗效

2021-11-12

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Cancer Commun：一线VEGFR-TKI失败的mRCC患者中，二线axitinib联合抗PD-1抗体或axitinib单药治疗的疗效

2021-11-25

仁者大医 (审核中...)

前往app查看评论内容

#单药治疗#

Blood：西罗莫司+泼尼松龙 vs 西罗莫司单药治疗卡波西样血管内皮瘤

2022-09-05

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：采用卡博替尼单药治疗晚期软组织肉瘤

2022-11-11

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Eur Heart J：经皮冠状动脉介入治疗的慢性肾脏病患者替格瑞洛单药治疗效果如何？

2022-01-31

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Lancet：新型双GIP和GLP-1受体激动剂单药治疗可以显著改善糖尿病血糖和体重水平

2022-02-07

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Clin Cancer Res：PARP抑制剂Pamiparib单药治疗铂敏感/耐药性卵巢癌的疗效

2022-08-24

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Front Oncol：卡瑞利珠单抗联合索拉非尼vs 索拉非尼单药治疗晚期肝细胞癌（HCC）的有效性和安全性

2021-12-18

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享

2022-08-22

12498717m75(暂无昵称) (审核中...)

前往app查看评论内容

#单药治疗#

Diabetes Obes Metab：二甲双胍单药治疗2型糖尿病和既往3期慢性肾病的疗效

2021-11-12

科室
- - 订阅+
  - 更多科室
工具
服务